Contact

Prelimigaine Screening welcomes corrections, questions, or feedback about our coverage of Ibogaine Preparation and Screening: A Checklist. Our tone is independent and evidence-first; we do not provide medical or legal advice.

If you would like to report an error or suggest an improvement, please consult the site's editorial overview and return to our detailed description of how we work via the page explaining our approach at the About page on Prelimigaine Screening, which outlines editorial principles and sourcing.

Close-up detail photograph evocative of careful, clinical preparation and screening practices

Independence

Prelimigaine Screening is an independent information company; our content is not generated by or affiliated with treatment providers. For readers seeking clinical care, we recommend consulting licensed professionals and official guidance rather than relying on this site as a provider directory.

Clarity

Questions about corrections or sourcing are welcome. Readers sometimes point out evidence gaps; when that happens we log the note and revise content where warranted. For context on our remit, see the site's editorial overview on how Prelimigaine Screening curates and verifies information.

Accuracy

We prioritise accurate citations and transparent sourcing. If you believe an item is incorrect, please reference the passage and we will review it. Note that we cannot provide individualized medical advice through this contact channel.

How to reach us

At present there is no public email or phone listed for contact. We invite readers to check back periodically for published channels. For an explanation of our remit and the best way to submit editorial feedback, review our editorial outline on the About page.

Please note: Prelimigaine Screening is an independent information company, not a clinic or medical provider. Its content is not medical or legal advice.

Requesting corrections or feedback

If you have a factual correction or a sourcing note related to Ibogaine Preparation and Screening: A Checklist, we appreciate precise references (page, paragraph, or quoted text). While we do not yet publish a direct email, checking our editorial overview will show the steps we follow when assessing reader-submitted corrections; visit our editorial overview for details on what to include.

Alternative resources

For readers seeking clinical guidance outside this independent resource, established organizations and official guidance can help; for example, general pharmacology and safety information is available from authoritative sources such as the U.S. National Library of Medicine on the Ibogaine article on Wikipedia and established academic or governmental pages. We do not endorse treatments; these links are offered as starting points for further reading.